DailyDoctor Archive Specialties Get app
All emergency & critical care briefings

The edition · Emergency & Critical Care

Endoscopy within 6 hours for non-variceal upper GI bleeding did not beat endoscopy within 24

A meta-analysis of 10,785 patients finds no mortality or rebleeding benefit from ultra-early endoscopy; one in five septic shock patients meets new refractory criteria, with 64% mortality; and AI sepsis models look better on paper than they have yet proved at the bedside.

The edition in brief

A meta-analysis of nine studies (10,785 adults) with non-variceal upper gastrointestinal bleeding found endoscopy within 6 hours did not reduce mortality (OR 0.88, 0.58 to 1.34) or rebleeding (OR 1.23, 0.90 to 1.67) compared with later endoscopy, including in high-risk patients, but was linked to more ICU admission. In a US health system cohort of 15,732 patients with septic shock (published June 2026), 21.8% met consensus criteria for refractory septic shock, noradrenaline equivalent above 0.5 µg/kg/min with lactate above 2 mmol/L; their hospital mortality was 64.4%, with risk-adjusted odds 4.87 times higher. A meta-analysis of 34 mostly retrospective studies of AI sepsis prediction reported a pooled AUROC of 0.913 but a prediction interval of 0.66 to 0.98, with heavy reuse of the same public datasets. In a Dutch cohort of 18,798 ED-to-ICU admissions, longer transfer time was associated with higher mortality after cardiac arrest in academic hospitals and the reverse in non-academic teaching hospitals, with no association in sepsis, pneumonia or overdose.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free